DMAC logo

DiaMedica Therapeutics
DMAC

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$456.20M
EV
$401.15M
Shares Outstanding
56.07M
Beta
1.30
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
4
P/E 2025E
-
P/Revenue 2025E
-

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
-
Net Profit Margin 2025E
-
ROE 2025E
-
ROCE 2024
-53.27%

Dividends

DPS 2025E
-
Payout Ratio 2025E
-
Div. Yield 2025E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About DiaMedica Therapeutics Inc.

gainify
DMAC logo

DiaMedica Therapeutics Inc.

DMAC

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein,...

Sector

Healthcare

Industry

Biotechnology

CEO

Pauls, Dietrich

Employees

28

IPO Date

2012-08-03

Headquarters

301 Carlson Parkway, Suite 210, Minneapolis, Minnesota, 55305, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.